Page last updated: 2024-08-23

captopril and Encapsulating Peritoneal Sclerosis

captopril has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirahara, I; Kusano, E; Takai, S; Yamamoto, D	1

Other Studies

1 other study(ies) available for captopril and Encapsulating Peritoneal Sclerosis

Article	Year
Captopril directly inhibits matrix metalloproteinase-2 activity in continuous ambulatory peritoneal dialysis therapy. Clinica chimica acta; international journal of clinical chemistry, 2010, May-02, Volume: 411, Issue:9-10 Topics: Ascitic Fluid; Biocatalysis; Captopril; Catalytic Domain; Female; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Middle Aged; Molecular Dynamics Simulation; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Fibrosis; Protein Binding	2010

Article

Year

Captopril directly inhibits matrix metalloproteinase-2 activity in continuous ambulatory peritoneal dialysis therapy.

Clinica chimica acta; international journal of clinical chemistry, 2010, May-02, Volume: 411, Issue:9-10

Topics: Ascitic Fluid; Biocatalysis; Captopril; Catalytic Domain; Female; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Middle Aged; Molecular Dynamics Simulation; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Fibrosis; Protein Binding

2010